nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Insomnia—Tamoxifen—pancreatic cancer	0.00402	0.00402	CcSEcCtD
Rimantadine—Insomnia—Erlotinib—pancreatic cancer	0.00398	0.00398	CcSEcCtD
Rimantadine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Rimantadine—Chills—Irinotecan—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Rimantadine—Dyspnoea—Erlotinib—pancreatic cancer	0.00392	0.00392	CcSEcCtD
Rimantadine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Rimantadine—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Rimantadine—Gait disturbance—Doxorubicin—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Rimantadine—Dry mouth—Sunitinib—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Rimantadine—Dyspepsia—Erlotinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Rimantadine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Rimantadine—Chills—Gemcitabine—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Rimantadine—Fatigue—Tamoxifen—pancreatic cancer	0.00383	0.00383	CcSEcCtD
Rimantadine—Decreased appetite—Erlotinib—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Rimantadine—Dysphagia—Docetaxel—pancreatic cancer	0.00381	0.00381	CcSEcCtD
Rimantadine—Constipation—Tamoxifen—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Rimantadine—Fatigue—Erlotinib—pancreatic cancer	0.00379	0.00379	CcSEcCtD
Rimantadine—Constipation—Erlotinib—pancreatic cancer	0.00376	0.00376	CcSEcCtD
Rimantadine—Bronchospasm—Docetaxel—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Rimantadine—Shock—Sunitinib—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Rimantadine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00364	0.00364	CcSEcCtD
Rimantadine—Anorexia—Sunitinib—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Rimantadine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—pancreatic cancer	0.00356	0.00356	CcSEcCtD
Rimantadine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Rimantadine—Abdominal pain—Erlotinib—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Rimantadine—Syncope—Irinotecan—pancreatic cancer	0.00345	0.00345	CcSEcCtD
Rimantadine—Insomnia—Sunitinib—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Rimantadine—Dyspnoea—Sunitinib—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Rimantadine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Rimantadine—Cough—Irinotecan—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Rimantadine—Dyspepsia—Sunitinib—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Rimantadine—Hypertension—Irinotecan—pancreatic cancer	0.00332	0.00332	CcSEcCtD
Rimantadine—Stomatitis—Docetaxel—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Rimantadine—Decreased appetite—Sunitinib—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00329	0.00329	CcSEcCtD
Rimantadine—Fatigue—Sunitinib—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Rimantadine—Cough—Gemcitabine—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Rimantadine—Constipation—Sunitinib—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Rimantadine—Hypertension—Gemcitabine—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Rimantadine—Asthenia—Tamoxifen—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Rimantadine—Convulsion—Fluorouracil—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Rimantadine—Confusional state—Irinotecan—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Rimantadine—Asthenia—Erlotinib—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Rimantadine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Rimantadine—Shock—Irinotecan—pancreatic cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Rimantadine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00304	0.00304	CcSEcCtD
Rimantadine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00304	0.00304	CcSEcCtD
Rimantadine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Rimantadine—Confusional state—Fluorouracil—pancreatic cancer	0.00303	0.00303	CcSEcCtD
Rimantadine—Abdominal pain—Sunitinib—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Diarrhoea—Erlotinib—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Oedema peripheral—Docetaxel—pancreatic cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Anorexia—Irinotecan—pancreatic cancer	0.00299	0.00299	CcSEcCtD
Rimantadine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Dizziness—Tamoxifen—pancreatic cancer	0.00294	0.00294	CcSEcCtD
Rimantadine—Tachycardia—Fluorouracil—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Rimantadine—Anorexia—Gemcitabine—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Rimantadine—Dizziness—Erlotinib—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Rimantadine—Anorexia—Fluorouracil—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Insomnia—Irinotecan—pancreatic cancer	0.00284	0.00284	CcSEcCtD
Rimantadine—Vomiting—Tamoxifen—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—pancreatic cancer	0.00282	0.00282	CcSEcCtD
Rimantadine—Rash—Tamoxifen—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Dermatitis—Tamoxifen—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Vomiting—Erlotinib—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Dyspnoea—Irinotecan—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Somnolence—Irinotecan—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Rimantadine—Headache—Tamoxifen—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Rimantadine—Rash—Erlotinib—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Rimantadine—Dermatitis—Erlotinib—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Rimantadine—Insomnia—Gemcitabine—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Dyspepsia—Irinotecan—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Headache—Erlotinib—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Chills—Docetaxel—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Rimantadine—Asthenia—Sunitinib—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Rimantadine—Decreased appetite—Irinotecan—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Rimantadine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Insomnia—Fluorouracil—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Somnolence—Gemcitabine—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00271	0.00271	CcSEcCtD
Rimantadine—Fatigue—Irinotecan—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Rimantadine—Constipation—Irinotecan—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Somnolence—Fluorouracil—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Rimantadine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Nausea—Tamoxifen—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Fatigue—Gemcitabine—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Rimantadine—Constipation—Gemcitabine—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Nausea—Erlotinib—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Decreased appetite—Fluorouracil—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Diarrhoea—Sunitinib—pancreatic cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Rimantadine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Rimantadine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Rimantadine—Dizziness—Sunitinib—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Abdominal pain—Irinotecan—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Rimantadine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Rimantadine—Vomiting—Sunitinib—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Rimantadine—Rash—Sunitinib—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Rimantadine—Dermatitis—Sunitinib—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Rimantadine—Headache—Sunitinib—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Rimantadine—Syncope—Docetaxel—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Rimantadine—Palpitations—Docetaxel—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Rimantadine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Rimantadine—Cough—Docetaxel—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Rimantadine—Convulsion—Docetaxel—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Rimantadine—Hypertension—Docetaxel—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Rimantadine—Nausea—Sunitinib—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Rimantadine—Asthenia—Irinotecan—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Rimantadine—Dry mouth—Docetaxel—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Rimantadine—Asthenia—Gemcitabine—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Rimantadine—Confusional state—Docetaxel—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Rimantadine—Diarrhoea—Irinotecan—pancreatic cancer	0.00215	0.00215	CcSEcCtD
Rimantadine—Shock—Docetaxel—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Rimantadine—Tachycardia—Docetaxel—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Rimantadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Rimantadine—Dizziness—Irinotecan—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Rimantadine—Anorexia—Docetaxel—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Rimantadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Rimantadine—Vomiting—Irinotecan—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Rimantadine—Dizziness—Fluorouracil—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Rimantadine—Rash—Irinotecan—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Dermatitis—Irinotecan—pancreatic cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Headache—Irinotecan—pancreatic cancer	0.00197	0.00197	CcSEcCtD
Rimantadine—Insomnia—Docetaxel—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Rimantadine—Vomiting—Gemcitabine—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Dyspnoea—Docetaxel—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Somnolence—Docetaxel—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Rash—Gemcitabine—pancreatic cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Dermatitis—Gemcitabine—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Headache—Gemcitabine—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Rimantadine—Vomiting—Fluorouracil—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Rimantadine—Dyspepsia—Docetaxel—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Rash—Fluorouracil—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Dermatitis—Fluorouracil—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Decreased appetite—Docetaxel—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Headache—Fluorouracil—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Fatigue—Docetaxel—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Nausea—Irinotecan—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Rimantadine—Constipation—Docetaxel—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Rimantadine—Chills—Epirubicin—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Rimantadine—Nausea—Gemcitabine—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Rimantadine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Rimantadine—Nausea—Fluorouracil—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Rimantadine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00177	0.00177	CcSEcCtD
Rimantadine—Tension—Epirubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Rimantadine—Abdominal pain—Docetaxel—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Rimantadine—Chills—Doxorubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Rimantadine—Agitation—Epirubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Rimantadine—Tension—Doxorubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Rimantadine—Syncope—Epirubicin—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Rimantadine—Cough—Epirubicin—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Rimantadine—Asthenia—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Rimantadine—Diarrhoea—Docetaxel—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Rimantadine—Cough—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Rimantadine—Shock—Epirubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Rimantadine—Dizziness—Docetaxel—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—pancreatic cancer	0.00139	0.00139	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Rimantadine—Vomiting—Docetaxel—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Rimantadine—Rash—Docetaxel—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Rimantadine—Dermatitis—Docetaxel—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Rimantadine—Headache—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Rimantadine—Shock—Doxorubicin—pancreatic cancer	0.00133	0.00133	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Rimantadine—Nausea—Docetaxel—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Rimantadine—Constipation—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—pancreatic cancer	0.001	0.001	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—pancreatic cancer	0.000971	0.000971	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—pancreatic cancer	0.000967	0.000967	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—pancreatic cancer	0.00093	0.00093	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000926	0.000926	CcSEcCtD
Rimantadine—Rash—Epirubicin—pancreatic cancer	0.000922	0.000922	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—pancreatic cancer	0.000921	0.000921	CcSEcCtD
Rimantadine—Headache—Epirubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—pancreatic cancer	0.000895	0.000895	CcSEcCtD
Rimantadine—Nausea—Epirubicin—pancreatic cancer	0.000869	0.000869	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—pancreatic cancer	0.00086	0.00086	CcSEcCtD
Rimantadine—Rash—Doxorubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Rimantadine—Headache—Doxorubicin—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—pancreatic cancer	0.000804	0.000804	CcSEcCtD
